IBRX CIK: 1326110

ImmunityBio, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
billions USD
FY21:
0.33
FY22:
0.14
FY23:
0.29
FY24:
0.18
FY25:
0.31
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.13
FY22:
0.22
FY23:
0.21
FY24:
0.20
FY25:
0.19
Total assets
Change from FY21 to FY25
billions USD
FY21:
0.47
FY22:
0.36
FY23:
0.50
FY24:
0.38
FY25:
0.50

Liabilities & Equity

(negative)
Change from FY21 to FY25
billions USD
FY21:
0.37
FY22:
0.50
FY23:
0.06
FY24:
0.05
FY25:
0.06
(negative)
Change from FY21 to FY25
billions USD
FY21:
0.34
FY22:
0.31
FY23:
1.03
FY24:
0.82
FY25:
0.94
(positive)
Change from FY21 to FY25
billions USD
FY21:
−0.24
FY22:
−0.45
FY23:
−0.59
FY24:
−0.49
FY25:
−0.50
Total liabilities & equity
Change from FY24 to FY25
billions USD
FY21:
–
FY22:
–
FY23:
–
FY24:
0.38
FY25:
0.50

All amounts in billions USD Data source:SEC EDGAR